Functional movement disorder comorbidity in Parkinson's disease: Unraveling the web
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 82, 138-145
Abstract
No abstract availableKeywords
Funding Information
- Bial
- zambon
- Boston Scientific
- Madrid Neurology Association
- Michael J Fox Grant
- Italfarmaco
- Bial
- AbbVie
- Allergan
- ALTER
- Teva
- Movement Disorders Society
This publication has 51 references indexed in Scilit:
- A Bayesian account of 'hysteria'Brain, 2012
- “Silly Walks” in Parkinson's disease: Unusual presentation of dopaminergic‐induced dyskinesiasMovement Disorders, 2011
- Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodiesNeurology, 2010
- Psychogenic movement disordersCurrent Opinion in Neurology, 2009
- Evaluation of clinical diagnostic criteria for psychogenic movement disordersMovement Disorders, 2006
- Rating scale for psychogenic movement disorders: Scale development and clinimetric testingMovement Disorders, 2005
- Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinicsJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Psychogenic disorders in neurology: frequency and clinical spectrumActa Neurologica Scandinavica, 1990
- Hysteria and organic brain diseasePsychology and Psychotherapy: Theory, Research and Practice, 1975
- THE FUNCTIONAL OVERLAYThe Lancet, 1967